Published in Neurology on July 25, 2006
Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology (2010) 2.40
HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment. Nat Rev Neurol (2016) 1.71
Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol (2008) 1.64
Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol (2011) 1.29
Declined neural efficiency in cognitively stable human immunodeficiency virus patients. Ann Neurol (2009) 1.26
Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Int AIDS Soc (2010) 1.20
Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda. Neurology (2009) 1.20
Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy. AIDS Care (2009) 1.11
Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon. J Neurol Sci (2009) 1.07
Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection: a pilot study in Zambia, Africa. J Nerv Ment Dis (2012) 1.06
Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. J Neurovirol (2012) 1.00
Antiretroviral treatment is associated with increased attentional load-dependent brain activation in HIV patients. J Neuroimmune Pharmacol (2007) 0.98
A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale. PLoS One (2013) 0.97
Callosal degradation in HIV-1 infection predicts hierarchical perception: a DTI study. Neuropsychologia (2009) 0.94
HIV-1gp120 induces neuronal apoptosis through enhancement of 4-aminopyridine-senstive outward K+ currents. PLoS One (2011) 0.94
Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya. PLoS One (2012) 0.93
Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology (2012) 0.91
Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review. BMC Public Health (2014) 0.91
Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana. PLoS One (2011) 0.89
4-Aminopyridine improves spatial memory in a murine model of HIV-1 encephalitis. J Neuroimmune Pharmacol (2009) 0.89
Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study. Metab Brain Dis (2014) 0.84
Second assessment of NeuroAIDS in Africa. J Neurovirol (2008) 0.84
HIV-associated neurocognitive disorders: Five new things. Neurol Clin Pract (2015) 0.84
Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study. BMC Infect Dis (2012) 0.84
Normative scores for a brief neuropsychological battery for the detection of HIV-associated neurocognitive disorder (HAND) among South Africans. BMC Res Notes (2010) 0.84
Antiretroviral adherence and the nature of HIV-associated verbal memory impairment. J Neuropsychiatry Clin Neurosci (2011) 0.82
HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda. Metab Brain Dis (2014) 0.82
Neurocognitive deficits in HIV-infected women and victims of childhood trauma. AIDS Care (2012) 0.82
Neurology and the Global HIV Epidemic. Semin Neurol (2014) 0.81
Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol (2015) 0.81
Cognitive dysfunction among HIV positive and HIV negative patients with psychosis in Uganda. PLoS One (2012) 0.80
The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review. CNS Drugs (2016) 0.80
Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy. J Acquir Immune Defic Syndr (2015) 0.80
Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients. Arch Clin Neuropsychol (2011) 0.80
Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect. J Neurovirol (2013) 0.78
Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era. J Acquir Immune Defic Syndr (2016) 0.76
Relationship between HIV stage and psychomotor speed neurocognitive score at a Kenyan sub-county hospital. Afr J Prim Health Care Fam Med (2016) 0.75
Association between Plasma Leptin and Estrogen in Female Patients of Amnestic Mild Cognitive Impairment. Dis Markers (2015) 0.75
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med (2010) 12.08
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
Essential role for oncogenic Ras in tumour maintenance. Nature (1999) 6.51
Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol (2001) 4.94
Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet (1995) 4.31
Genital ulcers in Kenya. Clinical and laboratory study. Br J Vener Dis (1981) 3.62
HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology (2001) 3.55
Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol (1998) 3.51
Prevalence of child physical and sexual abuse in the community. Results from the Ontario Health Supplement. JAMA (1997) 3.24
Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect (2006) 3.16
Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology (2007) 3.14
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet (1999) 3.01
Analgesic efficacy of ultrasound-guided transversus abdominis plane block in patients undergoing open appendicectomy. Br J Anaesth (2009) 2.83
HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med (1998) 2.68
Mre11 protein complex prevents double-strand break accumulation during chromosomal DNA replication. Mol Cell (2001) 2.65
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone (2003) 2.51
Rolling out antiretrovirals in Africa: there are still challenges ahead. Clin Infect Dis (2005) 2.43
The 5'-proximal region of the wheat Cab-1 gene contains a 268-bp enhancer-like sequence for phytochrome response. EMBO J (1987) 2.31
Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J Gen Virol (1996) 2.25
One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry (1996) 2.18
Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology (2010) 2.17
Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology (2000) 2.09
HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS (2001) 2.08
Countercurrent immunoelectrophoresis of urine as well as of CSF and blood for diagnosis of bacterial meningitis. J Pediatr (1976) 2.00
Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest (1972) 1.93
Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetes. Diabetes Care (2001) 1.88
Size and motion of the mitral valve annulus in man. I. A two-dimensional echocardiographic method and findings in normal subjects. Circulation (1981) 1.88
Phytochrome activation of two nuclear genes requires cytoplasmic protein synthesis. EMBO J (1989) 1.81
Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) Urology (1996) 1.75
Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage. Mol Cell (2000) 1.75
Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest (2001) 1.73
Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis (2011) 1.70
Community falls prevention for people who call an emergency ambulance after a fall: randomised controlled trial. BMJ (2010) 1.64
Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol (2000) 1.60
Evaluating herbal medicine for the management of Herpes zoster in human immunodeficiency virus-infected patients in Kampala, Uganda. J Altern Complement Med (1999) 1.60
Estuary-associated syndrome in North Carolina: an occupational prevalence study. Environ Health Perspect (2001) 1.56
Stimulation of aggrecan synthesis in cartilage explants by cyclic loading is localized to regions of high interstitial fluid flow. Arch Biochem Biophys (1999) 1.56
Measurement in jejunal biopsies by computer-aided microscopy. J Clin Pathol (1980) 1.55
Abnormal homicide in Hong Kong. Br J Psychiatry (1973) 1.50
Antiretroviral therapy in sub-Saharan Africa. Lancet (1998) 1.49
Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology (2008) 1.44
Participatory evaluation of counselling, medical and social services of The AIDS Support Organization (TASO) in Uganda. AIDS Care (1997) 1.41
Ring chromosome 14: a distinct clinical entity. J Med Genet (1981) 1.39
Adalimumab-induced asthma. Rheumatology (Oxford) (2005) 1.38
Rifampicin antibiotic impregnation of the St. Jude Medical mechanical valve sewing ring: a weapon against endocarditis. J Thorac Cardiovasc Surg (1996) 1.38
Long-term results of electrophysiologically guided sotalol therapy for life-threatening ventricular arrhythmias. Am Heart J (1996) 1.38
Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells. Mol Biol Cell (1997) 1.37
Rapid identification of Candida dubliniensis using a species-specific molecular beacon. J Clin Microbiol (2000) 1.34
New cephalosporin antibiotic--cephaloridine. Clinical and laboratory evaluation. Arch Intern Med (1967) 1.34
The role of local estrogen biosynthesis in males and females. Trends Endocrinol Metab (2000) 1.33
5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol Cell Biol (2000) 1.31
Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir. Antiviral Res (2000) 1.30
The association of herpes simplex virus type 2 (HSV-2), Haemophilus ducreyi, and syphilis with HIV infection in young men in northern Thailand. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.25
Psychiatric disorders among war-abducted and non-abducted adolescents in Gulu district, Uganda: a comparative study. Afr J Psychiatry (Johannesbg) (2007) 1.25
In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis. J Antimicrob Chemother (1990) 1.25
Local estrogen biosynthesis in males and females. Endocr Relat Cancer (1999) 1.24
Third chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1986 and by the National Toxicology Program through June 1987. Environ Health Perspect (1990) 1.24
Upper gastrointestinal endoscopy performed by nurses: scope for the future? Gut (2003) 1.23
Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery (2000) 1.22
Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells. Oncogene (1999) 1.22
Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS (1997) 1.21
Patterns of onset and cessation of drug use over the early part of the life course. Health Educ Behav (1997) 1.21
The management of compound leg injuries in the West Midlands (UK): are we meeting current guidelines? Br J Plast Surg (2005) 1.21
Surface and subsurface morphology of bovine humeral articular cartilage as assessed by atomic force and transmission electron microscopy. J Struct Biol (1997) 1.20
Expression of murine 21-hydroxylase in mouse adrenal glands and in transfected Y1 adrenocortical tumor cells. Proc Natl Acad Sci U S A (1985) 1.20
Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda. Neurology (2009) 1.20
A morphological study of penile chancroid lesions in human immunodeficiency virus (HIV)-positive and -negative African men with a hypothesis concerning the role of chancroid in HIV transmission. Hum Pathol (1996) 1.19
Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype. Clin Pharmacol Ther (2007) 1.18
Collagen in the egg shell membranes of the hen. Dev Biol (1984) 1.16
Epithelial cell growth and differentiation. III. Promoting diversity in the intestine: conversations between the microflora, epithelium, and diffuse GALT. Am J Physiol (1997) 1.15
Laboratory diagnosis of Haemophilus ducreyi: sensitivity of culture media. Diagn Microbiol Infect Dis (1986) 1.15
Trimethoprim sulphamoxole in the treatment of chancroid. Comparison of two single dose treatment regimens with a five day regimen. J Antimicrob Chemother (1985) 1.15
Sacroiliitis presenting as sciatica. Rheumatology (Oxford) (2005) 1.14
The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. Br J Cancer (2003) 1.14
Risk factors in onychocryptosis. Br J Surg (1989) 1.14
Congenital coronary artery aneurysms. Br Heart J (1974) 1.13
Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell Immunol (1994) 1.13
The role of mechanical loading histories in the development of diarthrodial joints. J Orthop Res (1988) 1.13
Macrosocial and environmental influences on minority health. Health Psychol (1995) 1.12
Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thromb (1991) 1.11
Chloroquine as a probe for antigen processing by accessory cells. Transplantation (1982) 1.11
Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology (2003) 1.10
Allograft heart valve sterilization: a six-year in-depth analysis of a twenty-five-year experience with low-dose antibiotics. J Thorac Cardiovasc Surg (1995) 1.10